Skip to Content

Global X Funds Global X China Biotech Innovation ETF

CHB
$--
Today’s Change
-- (--)

Snapshot
*

Inception Date
Sep 22 2020
Expense Ratio
0.65%
Type
Global Ex. US Equities
Fund Owner
Global X
Volume (1m avg. daily)
$2,315
AUM
$2,000,025
Associated Index
Solactive China Biotech Innovation Index
Inverse/Leveraged
No
Passive/Active
Passive
Fractionable on Composer
No
Prospectus

Top 10 Holdings

2269
Wuxi Biologics (Cayman) Inc.
8.85%
300122
Chongqing Zhifei Biological Products Company - Ordinary Shares - Class A
8.38%
000661
Changchun High & New Technology Industries Group Inc. - Ordinary Shares - Class A
7.81%
1093
CSPC Pharmaceutical Group Limited.
7.11%
300142
Walvax Biotechnology Company Ltd - Ordinary Shares - Class A
6.91%
002252
Shanghai Raas Blood Products Co Ltd - Ordinary Shares - Class A
4.89%
600161
Beijing Tiantan Biological Products Corporation Ltd. - Ordinary Shares - Class A
4.87%
002422
Sichuan Kelun Pharmaceutical Co Ltd - Ordinary Shares - Class A
4.75%
002007
Hualan Biological Engineering, Inc. - Ordinary Shares - Class A
4.53%
ZLAB
Zai Lab Limited - ADR
3.85%
Invest with CHB

What is CHB?

The Global X China Biotech Innovation ETF (CHB) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive China Biotech Innovation Index. The index is designed to track performance of Chinese companies that are active in the fi eld of Biotechnology. Securities must be listed on one of the following stock exchanges: Hong Kong Stock Exchange (HKSE), Shanghai-Hong Kong Stock Connect, Shenzhen-Hong Kong Stock Connect, New York Stock Exchange (NYSE) and NASDAQ. Eligible securities include H-Shares, Red Chips, P-Chips, A-Shares, ADRs and common stocks with a primary listing on the NYSE or NASDAQ. Each security must be classifi ed as Biotechnology by FactSet Industry.

ETFs related toCHB

ETFs correlated to CHB include CXSE, CNYA, ASHR

CHB
Global X Funds - Global X China Biotech Innovation ETF
CXSE
WisdomTree Trust - WisdomTree China ex-State-Owned Enterprises Fund
CNYA
BlackRock Institutional Trust Company N.A. - iShares MSCI China A ETF
ASHR
DBX ETF Trust - Xtrackers Harvest CSI 300 China A-Shares ETF
CHAU
Direxion Shares ETF Trust - Direxion Daily CSI 300 China A Share Bull 2X Shares
KBA
KraneShares Trust - KraneSharesBosera MSCI China A 50 Connect Index ETF
GXC
SSgA Active Trust - SPDR S&P China ETF
MCHI
BlackRock Institutional Trust Company N.A. - iShares MSCI China ETF
CHIQ
Global X Funds - Global X MSCI China Consumer Discretionary ETF
FXI
BlackRock Institutional Trust Company N.A. - iShares China Large-Cap ETF
CQQQ
Invesco Capital Management LLC - Invesco China Technology ETF

What is ETF correlation?

Correlation is a measure of the strength of the relationship between two ETFs. It quantifies the degree to which prices of the two ETFs typically move together.

Here, correlation is measured over the past year with the Pearson correlation coefficient (Pearon’s r), which ranges from -1 to 1.

Using ETF correlations in portfolio and strategy construction

ETF correlations can help you create investing strategies and portfolios. Use them to:

  • Build a diversified portfolio from uncorrelated or inversely correlated ETFs with the aim of minimizing portfolio risk.
  • Compare correlated or related ETFs to find one with a lower expense ratio or higher trading volume.
  • Create an investing strategy that hedges an ETF with an uncorrelated or inversely correlated ETF.

Automated Strategies
Related toCHB

#GLOBE

Follow the Global Trend

Category

Momentum, Lever Up, Go Global, Diversification

Risk Rating

Moderate

#PTC

Pick the Trending Commodity

Category

Living With High Inflation, Ride the Momentum

Risk Rating

Moderate

Create your own algorithmic trading strategy with CHB using Composer

FAQ

CHB is a Global Ex. US Equities ETF. The Global X China Biotech Innovation ETF (CHB) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive China Biotech Innovation Index. The index is designed to track performance of Chinese companies that are active in the fi eld of Biotechnology. Securities must be listed on one of the following stock exchanges: Hong Kong Stock Exchange (HKSE), Shanghai-Hong Kong Stock Connect, Shenzhen-Hong Kong Stock Connect, New York Stock Exchange (NYSE) and NASDAQ. Eligible securities include H-Shares, Red Chips, P-Chips, A-Shares, ADRs and common stocks with a primary listing on the NYSE or NASDAQ. Each security must be classifi ed as Biotechnology by FactSet Industry.

CHB tracks the Solactive China Biotech Innovation Index.

No, CHB is not actively managed. It is passively managed. In an actively managed fund, the fund manager makes decisions about how funds are invested. A passively managed fund typically tries to track or follow a market index.

Yes, CHB is passively managed. A passively managed fund typically tries to track or follow a market index. In an actively managed fund, the fund manager makes decisions about how funds are invested.

The 1-month return on CHB is 0.0332%. This is the percent change in the value of CHB over the most recent 1-month period. The 3-month return on CHB is -0.007%. This is the percent change in the value of CHB over the most recent 3-month period.

The standard deviation of CHB for the past year is 0.341%. Standard deviation is the typical amount that the daily returns vary from the mean of the returns over the time period, standardized to a period of a year.

ETFs similar to CHB include IXJ, SMH, and URA.

ETFs correlated to CHB include CXSE, CNYA, and ASHR.

ETFs that are inversely correlated to CHB include YANG, EDZ, and EPV.

Disclaimers

*

We show information directly obtained from our data provider, Xignite. Data shown here is provided by Xignite, an unaffiliated third party. Composer believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate.

**

We show information based on calculations performed by Composer using data from our provider. Information provided here is based on calculations performed by Composer using data sourced from Xignite, an unaffiliated third party. Composer believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.